Avalo Therapeutics • AVTX
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Garry A. Neil, M.D.$12.6M
Market Cap • 22/04/20242011
(há 13 anos)
2015
(9 years ago)
NASDAQ
Listagem
Rockville
Sede • Maryland20
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AVTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.